Updated on 28 January 2015
Mr Saleem Mohammed, director, Xcode Lifesciences
Singapore: We at Xcode feel that Digital health is going to take off in a big way in Asia. Personal healthcare records be it genetics, biomedical parameters, wearable devices, apps will come to vogue. All of these records will eventually contribute to bigdata through which accurate personalized predictions can be made to affect better health outcomes.
2014 was a great year for Xcode. We launched our new product 100&Life, which has been quite well received in India and abroad. In the short time that the product has been in the market we are already receiving positive feedback on its effectiveness in weight loss and wellness improvements of our clients. Genomics is coming of age in India and 2014 was a proof that it is here to stay. Consumers are knowledgeable, well informed and more aware about the benefits DNA analysis in preventing illnesses. Currently, genomics is the only way to prevent chronic illnesses before the onset of symptoms. Clients can learn about their predispositions and their unique nutritional and fitness genomics and take charge of their health, which is our mission.
We look forward to substantially scale our operations in 2015. In 2014, we established traction across different products in various international markets and are now ready to scale. Whether it is the 100&Life through corporates or Come Alive through salons and direct marketing, we have demonstrated month-on-month increase in customers. We expect this trend to accelerate in 2015.
Our focus is going to be towards growing the market across existing product lines. We already have a good pipeline through which we are confident of scaling to healthy figures. Secondly R&D has always been an area of focus for us. Whether it is development of better algorithms to increase predictability of illnesses or development of new product, we have always remained in the forefront. We will continue to identify novel areas through which genomics will be able to make a big impact.
With the new government there is a positive trend across most industries including biotechnology and healthcare. New lateral segments like wearable devices, genomics, home care, primary care clinics are going to boost growth as well as bring about more awareness in the consumers. Consumers are now seeing the benefits of self-mediated preventive healthcare through genetics as opposed to the conventional model of sickness care. We are bullish about the market in 2015 and like mentioned above new lateral segments are going to boost revenues in the life sciences industry